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Tryptophanyl-tRNA synthetase (WRS) is a member of aminoacyl-tRNA 
synthetases (ARSs) and is an essential enzyme in protein synthesis. Recently, it is 
well known that these ARSs exhibit various biological functions in addition to 
their essential functions. Mini-WRSs lacking an extra N-terminal domain have 
been shown to inhibit angiogenesis. However, the secretion and function of the 
full-length WRS (FL-WRS) remain unknown. Here I report that the FL-WRS, but 
not mini-WRS, is rapidly secreted upon pathogen infection to prime innate 
immunity. Blood levels of FL-WRS were increased in the sepsis patients 
compared with healthy subjects, but not in those with sterile inflammation.  
FL-WRS, which was present in cytoplasm of human monocytes, was secreted 
in a few minutes when pathogenic infectious agents (bacteria, viruses, fungi, etc.) 
invaded. The secreted FL-WRS, in combination with the TLR4-MD2 complex, 




neutrophil infiltration through chemokine secretion, thereby eradicating the 
infectious agent initially. The N-terminal 154 amino acid eukaryote-specific 
peptide of WRS was sufficient to recapitulate FL-WRS activity and its interaction 
mode with TLR4-MD2 is suggested.  
Administration of FL-WRS into Salmonella typhimurium–infected mice 
reduced the bacteria counts in tissues and improved mouse survival, whereas its 
titration with the specific antibody aggravated the infection. These results suggest 
that FL-WRS acts as an early defense system to prevent pathogens from infesting 











Sepsis, or the invasion of microbial pathogens, is characterized by an 
overwhelming systemic inflammatory reaction, which can lead to severe sepsis 
and septic shock(van der Poll and Opal, 2008). During microbial infection, 
prompt and efficient innate inflammatory response is required for the elimination 
of microbial in host cells. Firstly, defensins and lysozymes directly kill 
microorganisms and digest bacterial cell walls. However, avoidance strategies of 
pathogens and multiplication of the pathogen to sufficient numbers overwhelm the 
immediate innate host defense. After entering tissues, innate immune cells sense 




patterns (PAMPs) from invading pathogens with pattern recognition receptors 
(PRRs) such as Toll-like receptors (TLRs)(Dziarski and Gupta, 2000). TLR2 and 
TLR4 are surface expressed PRRs that recognize microbial lipopeptides and 
lipopolysaccharide (LPS), respectively (Takeuchi et al., 1999). For ligand recognition, 
TLR4 forms a homodimer (Park et al., 2009), whereas TLR2 forms a heterodimer with 
other TLRs such as TLR1 or TLR6. Normally, the extracellular domain of TLR4 forms a 
stable heterodimer with myeloid differentiation factor 2 (MD2), and dimerization of the 
TLR4-MD2 complex occurs in the presence of LPS that is delivered to MD2 (Park et al., 
2009). As a consequence of endocytosis of the receptor-ligand complex, multiple 
signaling components are activated, including NF-κB. Ultimately activation of these 




of innate inflammatory cells, such as neutrophils and monocytes/macrophages, which 
eliminate pathogens by phagocytosis (Fitzgerald et al., 2001).  
Although many exogenous ligands capable of triggering innate immunity have been 
reported, the existence of endogenous molecules that specifically mediate pathogen 
infection in humans has only been suggested. For instance, chromatin-associated protein 
high-mobility group box 1 (HMGB-1), a highly conserved DNA binding protein, is 
known to be secreted by infection and to interact with TLR2 and TLR4. However, 
HMGB-1 does not appear to function rapidly at the frontline of infection, but rather at a 
relatively late phase, in the range of 8-12 hr after pathogen exposure (Wang et al., 1999). 
These data suggest that HMGB-1 expression is induced by TNF-α and IL-1β from 




HMGB-1 increased over 18-72 hr period after infection and negatively affected survival 
(Yang et al., 2004). Heat shock protein 70 (HSP70) has been also suggested as a putative 
endogenous ligand for TLR4 (Vabulas et al., 2002), but it is not yet known whether the 
HSP70 secretion is associated only with infection. An important effect of the interaction 
between pathogens and tissue macrophages is activation of macrophages to release 
cytokines that bring phagocytes (monocytes, neutrophils and macrophages) to 
efficiently eliminate the microorganism invasion(Brown and Treacher, 2006; 
Chaplin, 2010). There are a number of mechanisms in which biologically active 
cytokine concentrations reach the relevant target cells, where the level and 
duration of cytokine synthesis do not result in inadequate activation of the 




Aminoacyl-tRNA synthetases (ARSs) play an essential role in catalyzing the 
esterification reactions that link amino acids with cognate tRNAs for protein 
synthesis. Some ARSs are secreted by cells to undertake extracellular, non-
canonical functions even under conditions that may interfere with their canonical 
mission (Son et al., 2014). Tryptophanyl-tRNA synthetase (WRS) freely exists in 
two forms in the cytoplasm: one as a full-length (FL) form and the other as a 
truncated form. The major truncated version, namely mini-WRS, is an 
alternatively spliced gene product with a key absence of its NH2-terminal domain 
(a.a.1–47). Human FL-WRS has the unique NH2-terminal eukaryotic extension 
domain (a.a.1–154), which is absent from prokaryotic WRS. Immune stimuli like 




1993; Shen et al., 1996). It is known that infection conditions such as intracellular 
pathogenic parasites, Vibrio cholera, Cytomegalovirus (CMV) and H3N2 swine 
influenza virus highly increased WRS expression level as well (Ellis et al., 2015) 
(Wu et al., 2013; Zhu et al., 1998). The development of eukaryotic specific 
extension domain of WRS assumed to contribute to immune function during 
infection. However, the functional activity of FL-WRS has not been reported and 
the only cleavage form of WRS has a potent anti-angiogenic effect (Wakasugi et 
al., 2002). In this study, I demonstrated that FL-WRS is actively secreted 
endogenous protein upon bacterial infection and amplified the infection signaling 






Signaling network mediated by mammalian aminoacyl tRNA synthetases 
(AARSs) Nine different AARSs ( EP: glutamyl-prolyl-, I: isoleucyl-, L: leucyl-, 
M: methionyl-, Q: glutaminyl-, R: arginyl-, K: lysyl-, and D: aspartyl-tRNA 
synthetase) form a macromolecular complex with three nonenzymatic factors, 
AIMP1/p43, AIMP2/p38 and AIMP3/p18. Among noncomplex forming AARSs, 
WRS (tryptophanyl-tRNA synthetase) is secreted and its N-terminal truncation 




cadherin (Wakasugi et al., 2002) 
  Atsushi Otani et al. PNAS 2002;99:178-183 
Schematic representation of human WRS variants. Shaded regions of WRS 
represent the NH2-terminal appended domain. Numbers on the left and right 
correspond to the NH2- and COOH-terminal residues relative to the human full-
length enzyme, respectively. WRS variants active (+) or inactive (−) in 
aminoacylation or angiogenesis inhibition assays are indicated. The NH2 domain 
of WRS has sequence similarity to the extra domains of human GluProRS (a 
fusion of glutamyl- and prolyl-tRNA synthetases), MetRS, GlyRS, and HisRS 






Chapter I. WRS is Secreted from Monocytes by Pathogenic Infection 
Increase of WRS Serum Levels in Sepsis Patients  
WRS is a constitutively expressed cytosolic protein and plays important 
intracellular roles. Current evidence indicates that WRS is released into 
extracellular serum and involves immune regulation (Bao et al., 2013). To 
examine whether WRS secretion into blood correlates with infection, I measured 
serum levels of WRS in sepsis patients with systemic infection. Compared with 
healthy controls (n=20, 0.18 ± 0.06 ng/mL), the levels of WRS increased about 
27-fold in the sepsis patients with bacterial infection (n=100, 5.0 ± 0.63 ng/mL, 
p<0.0001) (Figure I-1a and Table 1). In contrast, there were no differences in the 
levels of glycyl-tRNA synthetase (GRS) (Figure I-1b). Although lysyl-tRNA 




healthy controls, the difference was statistically not as significant as WRS (Figure 
I-1c) and additional analysis with more individuals seems to be necessary to reach 
convincing conclusion. Levels of WRS, but not GRS and KRS, also increased in 
fungal sepsis patients (n=8, 4.52 ± 1.83 ng/mL, p<0.01) (Figure I-1d, e, f, and 
Table 1). I did not observe significantly different levels of WRS between the 
patients infected with Gram-negative (n=62, 5.98 ± 0.93 ng/mL), Gram-positive 
bacteria (n=25, 2.87 ± 0.72 ng/mL), and fungi (n=8, 4.52 ± 1.83 ng/mL), or 
between those with multiple (n=11, 3.53 ± 1.22 ng/mL) and single pathogen 
infection (n=94, 5.01 ± 0.67 ng/mL, p>0.05) (Figure I-1g and 1h). To test whether 
WRS serum levels are increased in inflammatory immune disorders unrelated to 
infections, I measured WRS levels in sterile inflammatory disorders including 
systemic inflammatory response syndrome (SIRS), asthma patients (ASA), 
autoimmune disease patients diagnosed with rheumatoid arthritis (RA) and 




controls (Figure I-1i, j, k). These data suggest that systemic infections would 
induce secretion of WRS into blood. 
 
WRS-Specific Secretion by Pathogen Infection  
To confirm that infection would induce the secretion of WRS, I measured the 
levels of WRS secreted from cultured human peripheral blood mononuclear cells 
(PBMCs) that were infected with various pathogens. Human PBMC were cultured 
for 2 hours at a density of 2 × 10
6
 cells /mL and infected with 2 × 10
6
 CFU of S. 
typhimurium (MOI = 1). Culture supernatants cultured for two hours after 
infection were precipitated with TCA and immunoblot experiments were 
performed on various kinds of ARS. Consistent with the data from sepsis patients, 
only WRS was detected in the culture medium among the tested ARSs including 
WRS, methionyl-tRNA synthetase (MRS), aspartyl-tRNA synthetase (DRS), GRS, 
histidyl-tRNA synthetase (HRS), KRS, and ARS-interacting multi-functional 




(Figure I-2a). Gram-negative bacteria such as S. typhimurium and E. coli, gram-
positive bacteria such as L. monocytogenes and S. aureus, and Candida albicans, 
which is a fungus, also secrete WRS in human peripheral blood mononuclear cells 
(Figure I-2b). In addition, WRS secretion was induced by infection with 
respiratory cell virus (RSV) and PR8 influenza virus (Figure I-2c). This indicates 
that WRS responds to a variety of pathogens, not to certain bacteria. At this time, 
no significant secretion of HMGB1, HSP70 and lactate dehydrogenase (LDH) 
was observed (Figure I-2b and 2d). In vivo experiments using mice also confirmed 
the secretion of WRS by S. typhimurium infection. After intraperitoneal injection 
of S. typhimurium into the peritoneal cavity of mice, the amount of WRS was 
determined by mouse WRS ELISA. The secretion levels of WRS were dependent 
on the CFU of S. typhimurium. 1X10^8 CFU S. typhimurium -infected mice began 
to die from 8 hours, so WRS secretion was observed only up to 4 hours (Figure I-
2e). Finally, I determined whether the release of WRS was from first-responder 




associating with the vascular endothelium and sense the bacterial and viral 
component (Murray and Wynn, 2011; Shi and Pamer, 2011). B cells, T cells, NK 
cells and monocytes were isolated from PBMC with a commercial MACS 
depletion kits and infected with S.typhimurium for 2hrs. Among these immune 
cells, only monocytes released WRS following S.typhimurium bacterial infection 
(Figure I-2f). These data suggest that sensing of infection by patrolling monocytes 
promptly and actively release WRS.  
 
Prompt Secretion of WRS Prior to TNF-α upon Infection 
Many DAMPs (Damage-Associated Molecular Pattern molecules) are nuclear or 
cytoplasmic molecules and released outside the cell upon infection or tissue injury. 
DAMPs, including high mobility group box 1 protein (HMGB-1) and heat-shock 
proteins (HSPs) are passively released by necrotic cells or actively secreted in the 




actively in the early time following bacterial infection. To investigate the 
importance of the immediate release of WRS at the early time, kinetics of the 
secretion of both WRS and TNF-α were analyzed by western blot and WRS 
ELISA method. TNF-α is one of the most important pro-inflammatory cytokines 
initiating innate inflammatory responses following bacterial infection; hence, I 
compared its kinetics to that of WRS. The presence of FL-WRS was apparent 
from 15 min following S.typhimurium infection and gradually increased in the 
supernatant, while secretions of mini-WRS were minimal. The levels of mature 
TNF-α in the supernatant were detectable at 120 min. (Figure I-3a and 3b). The 
levels of WRS mRNA were not changed up to 120min, indicating that preexisting 
WRS molecules were released immediately upon bacterial infection without 
induction of gene expression. Whereas mRNA level of TNF-α was increased at 
30min and high expression levels were apparent at 120 min (Figure I-3c). I further 
investigated the secretion of WRS and TNF-α at late time after S.typhimurium 




normal intracellular WRS level within 24 hr. In contrast, TNF-α mRNA synthesis 
reached its peak levels in 2 hr after infection and then decreased (Figure I-3d and 
3e) 
 
Endocytosis of Pathogenic Components Affects WRS Secretion 
I have determined whether WRS is secreted by TLR ligands or by inflammatory 
stimulus. Treatment of PBMC with LPS, Pam3CSK4, CpG oligonucleotides 
(ODN) and Zymosan resulted in dose-dependent WRS secretion. In contrast, other 
stimulus such as the inflammatory elements including TNF-α, liposomes or PS 
particles did not induce WRS secretion for up to 2 hours (Figure I-4a). I 
monitored the effect of endocytosis inhibitors such as dynasore and cytochalasin 
D to determine if the endocytosis of pathogens is required for WRS secretion. 
Endocytosis inhibitors were pretreated 30 minutes and found that the inhibitor-
treated cells lost the WRS secretion activity (Figure I-4b). These results suggest 




stimuli, would be required for the WRS secretion. In summary, FL-WRS appears 
to be secreted specifically from mononuclear cells in response to the endocytosis 
of the pathogen, and this event occurs prior to the activation of previously known 
innate immunity. 
Chapter II. FL-WRS, but not Mini-WRS Activates Macrophages to 
Prime Innate Immune Responses  
 
FL-WRS, but not Mini-WRS, Induces Cytokine/Chemokine Productions  
Since amplification of innate immunity depends on the productions of chemokines 
and the recruitments of inflammatory cells, particularly neutrophils and 
macrophages. Therefore, I screened whether FL-WRS would induce chemokine 
and cytokine production in human PBMCs using microarray. FL-WRS induces 
innate inflammatory responses through macrophage activation, whereas mini-




cytokine/chemokine secreted by FL-WRS, human PBMC were treated with FL-
WRS or mini-WRS and then subjected to microarray. The mean pixel of TNF-α, 
MIP1-α, MIP1- IL-6 and IL-8 were highly increased compared with control 
(Figure II-1a). In addition, human monocytes were treated with FL-WRS or mini-
WRS and cultured for 3 hours. The amount of TNF-α, MIP1-α and MIP1-β 
protein present in the culture supernatant was measured by ELISA Kit (San Jose, 
CA, USA and R & D systems). FL-WRS not only secreted TNF-α, MIP1-α and 
MIP1-β proteins by activating human PBMCs, but also increased mRNA 
expression levels. On the other hand, mini-WRS had no effect on cytokine 
secretion (Figure II-1b and 1c). 
To investigate the type of immune cells responding to FL-WRS, FL-WRS 
was treated on various immune cells and the relative fold change of the secreted 
TNF-α and MIP1-α were determined. Mouse primary T cells, neutrophils, 
natural killer cells (Zhu et al.), monocytes and macrophages were prepared using 




obtained cells showed more than 95% purity when analyzed by flow cytometry. 
The primary immune cells were cultured for 18 hrs after treatment with FL-WRS 
(100 nM), mini-WRS (100 nM) or LPS (100 ng / ml) according to the 
experimental conditions and the amounts of TNF-α and MIP1-α proteins were 
measured by ELISA kit. As a result, LPS significantly induced TNF-α and 
MIP1-α secretion in most immune cells, whereas FL-WRS showed the greatest 
effect in monocytes and BMDM. Mini-WRS also had no effect on cytokine 
secretion (Figure II-1d). In order to eliminate the endotoxin contamination of FL-
WRS protein purified from E. coli, FL-WRS treated with heat or trypsin had no 
effect on TNF-α secretion after BMDM treatment (data not shown). In addition, 
cytokine secretion by FL-WRS was not decreased by polymyxinB, whereas the 
positive control LPS significantly decreased cytokine secretion by polymyxinB 
treatment (Figure II-1e). I prepared recombinant FL-WRS and mini-WRS from 




protein also induced chemokine secretion to a level similar to those induced by E. 
coil-expressed FL-WRS (Figure II-1f)  
 
FL-WRS Increases the Infiltration of Phagocytes via Macrophage Activation 
The effect of FL-WRS on the migration of immune cells was examined using a 
transwell migration assay (Figure II-2a). BMDMs were treated with FL-WRS or 
mini-WRS and cultured for 18 hours. The culture was transferred to a 24-well 
plate. Various primary immune cells were isolated from the mice and then placed 
in the upper part of the migration chamber and incubated at 37° C for 4 hours. As 
a result, it was observed that the culture supernatant of the FL-WRS treated-
BMDM greatly increased monocyte, neutrophil and BMDM infiltration. In 
contrast, the FL-WRS protein itself (data not shown) or mini-WRS-treated culture 
supernatant had no effect on cell migration. To investigate the effect of FL-WRS 
on the innate immune response, in vivo imaging of neutrophil, 




mini-WRS was injected into transgenic mice overexpressing GFP-LysM, and the 
inflow of neutrophil, monocyte, macrophages exhibited by green fluorescence 
was photographed for up to 4 hours. As a result, mice injected with FL-WRS 
showed a marked increase in neutrophils infiltration compared to the control and 
mini-WRS injected mice (Figure II-2b). When mice were i.p. injected with FL-









macrophages infiltrated into peritoneal exudate were increased 15-, 
9-, and 2-fold, respectively, compared with those injected with mini-WRS and the 
PBS-treated control (Figure II-2c). To confirm whether the induction of innate 
immune response by FL-WRS is macrophage-dependent, liposomal clodronate 
was treated for 24 hours to produce macrophage-deficient mice. Splenocytes 
obtained from macrophage-deficient mice showed a decrease in secretion of TNF-
α and MIP1-α by FL-WRS, as well as inhibition of intraperitoneal neutrophil 





FL-WRS Increases Phagocytosis via Macrophage Activation. 
Matured or activated macrophages express high levels of CD80 (B7-1) or CD86 
(B7-2) on the surface and interact with CD28 to provide a second signal to the T 
cell. Other molecules like CD40 serves as co-stimulator or amplifier of initial 
stimulatory signal to T-cell. I examined whether FL-WRS affects the expression 
of cell surface molecules in macrophages. BrdU cell proliferation experiments 
confirmed that cell proliferation was reduced when FL-WRS was treated to 
BMDM cells. Flow cytometry analysis using Cd11b and F4/80 at the top of Fig. 
7b indicates that bone marrow cells were well differentiated into BMDM. The 
differentiated BMDMs were treated with FL-WRS or mini-WRS (100 nM) for 18 
hours and CD40, CD80 and CD86 protein expression levels were measured by 
flow cytometry. These results indicate that BMDMs are matured by FL-WRS 
(Figure II-3a and 3b). To determine how FL-WRS functions in this rapid response 
to infection, I checked whether FL-WRS would affect the phagocytic activities in 




imaging technology. The number of phagocytic cells was significantly increased 
in the FL-WRS-treated mice, compared to those in mini-WRS- and PBS-treated 
mice (Figure II-3c). I also examined the effect of FL-WRS on the phagocytosis of 
bone marrow-derived macrophage (BMDM) (Figure II-3d). BMDM was cultured 
in a 96-well culture dish overnight, then replaced with RPMI medium without M-
CSF, and treated with FL-WRS or mini-WRS for 18 hours. After washing the 
cells, 100 μL of fluorescein-labeled E. coli bioparticles (Vybrant phagocytosis 
assay kit, Invitrogen) was added and incubated for 2 hours, after which the culture 
was removed and 100 μL of trypanblue for 1 min to inhibit autofluorescence. The 
fluorescence signal from the macrophage was measured at 485 (excitation) and 
520 nm (emission) wavelengths and the phagocytosis index was calculated. The 
results showed that the FL-WRS-treated BMDM increased the phagocytic index 
more than 3-fold compared to the control group. 
 




In order to investigate the effect of FL-WRS on in vivo bacterial infection 
inhibition, the survival rate of S. typhimurium-infected mice and S. typhimurium 
adhesion and uptake by infiltrated neutrophil were confirmed after infection. 
Fluorescence-labeled S.typhimurium (FITC-ST) was injected intraperitoneally 
into mice (C57BL / 6 mice, 9-12 week old female). Five minutes later, PBS or 
mouse FL-WRS (mFL-WRS) or mouse ΔN51-WRS (mΔN51-WRS) protein was 
injected. Two hours after infection, mice were sacrificed and the cells in the 
peritoneal cavity were separated, stained with Ly6G antibody, and analyzed for 
flow cytometry. As a result, the number of uptake of S. typhimurium by 




 neutrophil) was 
significantly increased in the mFL-WRS treated group compared to the PBS-
treated control group (Figure II-4b). Animal experiments with mice were carried 
out according to the outline of experiment (Figure II-4a) and the degree of 
bacterial clearance in the spleen and liver was observed 4 hours after infection. 




serially diluted and spotted on NB agar medium. After culturing at 37 °C for 24 
hours, the bacterial CFU was calculated and analyzed. As a result, it was 
confirmed that bacterial CFU in the spleen and liver was significantly decreased 
in the mFL-WRS treated group. Immunohistochemistry also confirmed that the 
number of bacteria in the spleen and liver decreased (Figure II-4c and 4d). This 
shows that in the spleen of FL-WRS-treated mice, bacteria were eliminated before 
they caused cell infections. To investigate the effect of mFL-WRS on the survival 
rate of S. typhimurium-infected mice, animal experiments using mice were 
performed according to the outline of the experiment and survival analysis was 
performed. mice were injected with PBS, mFL-WRS, or mΔN51-WRS at 5 
minutes after intraperitoneal injection of 1X107 CFU S. typhimurium. Survival 
rates of 24, 48, 72, and 96 hours after infection were expressed as survival plots 
according to treatment conditions. As a result, the survival time of mFL-WRS 
injected group was significantly longer than that of control group or mΔN51-WRS 




In addition to S. typhimurium, a gram-negative strain, L. monocytogenes-
infected mice also showed decreased numbers of bacteria in the spleen and liver 
and increased survival in the mFL-WRS-treated group (Data not shown). These 
results show that FL-WRS reduces the mortality rate of bacterial infected mice 
by activating innate immune responses early in infection 
 
Neutralization of FL-WRS Aggravates Bacterial Infection  
In order to further validate the role of FL-WRS as an initial immune defense in 
vivo infection, scFv antibodies neutralizing the function of FL-WRS were 
constructed. A 4G1 scFv that specifically binds to the N154 peptide of human 
WRS was selected by panning a library of human single chain variable fragments 
(scFv) expressed in phage (Figure II-5a). The 4G1 scFv clone binds to the FL-
WRS protein but does not bind to the mini-WRS protein. In addition, when FL-
WRS and 4G1 were simultaneously treated with PMA-differentiated THP-1 cells, 




other hand, the GRS scFv antibody used as a negative control did not affect the 
amount of TNF-α secreted by FL-WRS (Figure II-5b and 5c). When S. 
typhimurium was injected into the abdominal cavity simultaneously with scFv 
4G1 or scFv 2B (bound to GRS), the production of TNF-α and MIP-1α was 
significantly reduced in scFv 4G1-treated mice. In addition, intraperitoneal 
neutrophil infiltration was reduced and survival rate was decreased in scFv 4G1 
treated mice. The scFv 2B-treated mice used as negative controls did not 
significantly affect cytokine, neutrophil infiltration, and survival rates (Figure II-
5d, e, f). All these results further demonstrate the importance of FL-WRS in vivo 
in the early immune defense system. 
 
Chapter III. FL-WRS Activates Innate Immunity via Dimerization 





Mechanism of Innate Immune Activation by FL-WRS via TLR4-MD2 
To understand molecular mechanism of FL-WRS, I screened whether FL-WRS 
acts as a ligand for innate immune receptors to induce early immune activation. 
Figure III-1a shows experimental results using the NF-kB luciferase reporter 
system. HEK293 cells expressing PRR such as NF-kB reporter, toll-like receptor 
(TLR), NOD-like receptor (NLR) and C-type lectin receptor (CLR) were 
stimulated with FL-WRS for 16-20 hours (Relative activity, (%)). Experimental 
results showed that FL-WRS acts as a ligand for TLR2 and TLR4/MD2 (myeloid 
differentiation factor 2) receptors. I examined the ability of FL-WRS to activate 
NF-kB signaling in immune cells and examined the pattern-recognition receptor 
(PRR) associated with the immune activation of WRS. In the FL-WRS-treated 
macrophages, the levels of NF-κ B p65 in the nucleus, cytoplasmic 
phosphorylated IκB-α (p-IκB-α) and phosphorylated ERK (p-ERK) level were 
significantly increased in a dose-dependent manner. In contrast, mini-WRS-




1b). Experiments were conducted to confirm the effect of TLR receptor and MD2 
expression on the secretion of cytokines in BMDM. BMDM were transfected with 
siRNA for each TLR and MD2 for 48hrs, and then treated with FL-WRS for 18 
hours and levels of TNF-α and MIP-1α secreted from BMDM were measured by 
ELISA method. The results showed that the FL-WRS-induced TNF-α and MIP-1 
α productions were significantly inhibited when TLR4, MD2, and TLR2 (to lesser 
degree) were suppressed (Figure III-1c).  
I examined the manner in which KO (knock-out) mice that do not express 
TLR2, TLR4, or MD2 respond to FL-WRS. BMDM derived from TLR2 KO, 
TLR4 KO, or MD2 KO mice showed a marked decrease in the amount of MIP-1α 
and TNF-α secreted in response to FL-WRS, compared with BMDM derived from 
wild-type (WT) mice (Figure III-1d). In addition, phagocytic activities in BMDMs 




mice (Figure III-1e). The 
peritoneal exudate cells (PECs) were harvested 4 hours after intraperitoneal 






 Neutrophil) were significantly reduced than WT mice (Figure 
III-1f). Compared with TLR2 KO mice, TLR4 and MD2 KO mice showed almost 
complete inhibition of innate immune activation by FL-WRS, and TLR4 and 
MD2 expression inhibition effects were more pronounced than TLR2. While the 
i.p. injection of mFL-WRS after ST inoculation significantly diminished bacterial 
loads and improved survival rates in the TLR4
+/+ 
mice, these effects were not 
shown in TLR4
-/- 
mice (data not shown). These results suggest that FL-WRS acts 
on the NF-kB signaling pathway in macrophages and innate immune activation is 
mediated by TLR4/MD2 receptor.  
 
Direct Interaction of FL-WRS and TLR4-MD2  
To understand the mechanism by which WRS activates TLR4-MD2, I examined 
whether WRS directly binds to TLR4-MD2. The direct binding of WRS to TLR4 
and MD2 was confirmed by GST pull-down experiment (Figure III-2a). Pull-




GST-fused mini-WRS (GST/mini-WRS) increased the level of co-
immunoprecipitated MD2 and TLR4-MD2. As a result, FL-WRS was co-
immunoprecipitated with MD2, but not with TLR4. FL-WRS and MD2 are 
directly interacted but FL-WRS and TLR4 do not bind directly without MD2. 
Therefore, it shows the combination of FL-WRS and MD2 must precede binding 
to TLR4 to form a complex, Mini-WRS showed a decrease in the level of binding 
to MD2 compared with FL-WRS, but mini-WRS also showed a result of binding 
to MD2. On the other hand, both FL-WRS and mini-WRS did not bind to TLR4. 
To understand how FL-WRS would activate TLR4-MD2, I prepared a series of 
the N-terminal peptides (Figure III-2b) and compared their cytokine production 
activities. Among them, N154 showed the activity comparable to FL-WRS 
(Figure III-2c) and its activity showed the dependency on TLR2, TLR4, and MD2 
(Figure III-2d), proving that N154 is sufficient to mediate the activity of FL-WRS.  
The characteristics of the binding between WRS and TLR4-MD2 were studied 




that FL-WRS and mini-WRS could bind to MD2 with Kd of 190 and 200 nM, 
respectively (Figure III-2e), while they showed no binding signal to TLR4 (Figure 
III-2f). I also checked binding of the different N-terminal fragments to MD2 and 
TLR4. Despite the fact that N65 containing WHEP domain and even its shorter 
fragment, N47, showed the binding to both of MD2 and TLR4, they did not 
induce the cytokine production (Figure III-2b), further suggesting that binding to 
TLR4 and MD2 is not sufficient to work as an active ligand. Interestingly, N115, 
N125, and N135 showed no binding to MD2 and TLR4 (Figure III-2g and 2h) 
even though they contain the WHEP domain. Perhaps, the peptide region beyond 
N65 could mask the WHEP domain for the interaction with MD2. However, the 
peptides longer than N135 (N154 and N145) partially restored the binding to 
TLR4, but not MD2, with the cytokine-inducing activity suggesting that the 
peptide region beyond N135 might have an additional binding site for TLR4 and 





Modeling Study of the Interaction of WRS and TLR4-MD2 Dimers  
Based on the data above (Figure III-2) and previous modeling study of TLR4-MD2 
dimerization by homodimeric radioprotective 105 (RP105)/MD1 complex (Yoon et al., 
2011), I generated a binding model of WRS homodimer (Yang et al., 2003) with two 
TLR4-MD2 complexes using their respective crystal structures. The docking model 
suggested that the N-terminal WHEP domain (8-64 aa) of helix-turn-helix motif (marked 
red)
 
(Figure III-3a) would be inserted into the interface between TLR4 and MD2, 
making interactions with both proteins (Figure III-3b). This could explain why N47 is 
critical for the activity of FL-WRS. Further, the model with two TLR4-MD2 complexes 
suggests additional region spanning 145-152 aa (shown in red) that might interact with 
TLR4 in trans (Figure III-3c). Thus, N154 would be able to bring two TLR4-MD2 units 
for functional dimerization (Figure III-3c and 3d).  




make interactions with TLR4-MD2. Among them, the L10D mutation of FL-WRS 
almost completely ablated the cytokine production activity (Figure III-3e), further 
confirming the functional importance of N47 region. In addition, the N152G mutation 
also significantly reduced the cytokine-inducing activity, supporting the potential 
existence of the additional TLR4-binding site that would make an interaction with 
TLR4-MD2 in trans. Taken together; N154 would be fully active as a ligand, facilitating 
the dimerization of the two TLR4-MD2 units (Figure III-3f). However, the isolated 
WHEP domain (N65) can only bind one unit of TLR4-MD2 since it lacks the secondary 
TLR4-binding site that is present in N154. Although mini-WRS lacking N47 can bring 
the two TLR4-MD2 complexes into proximity through homodimerization of the WRS 
catalytic domain (Guo et al., 2010), they may not be able to induce the functional 









Immune Disorders. Serum levels of (a) WRS, (b) GRS, and (c) KRS in healthy controls 
(n=20) and bacterial sepsis patients (n=100) were measured by ELISA specific for each 
ARS. Serum levels of (d) WRS, (e) GRS, and (f) KRS in healthy controls (n=20) and 
fungal sepsis patients (n=8) were measured by ELISA. Comparison of serum levels of 
WRS in sepsis patients infected with (g) Gram-negative (n=62), Gram-positive (n=25) 
bacteria, and fungi (n=8), and (h) with a single (n=94) or multiple (n=11) pathogens. 
Serum levels of WRS (i) in healthy control (n=20) and SIRS patients (n=25), (j) in 
healthy control (n=22) and ASA patients (n=30), and (k) in healthy control (n=15), RA 
(n=30), and SS (n=45) patients were measured by ELISA. All data are presented as 
scatter dot with mean of triplicate measurements. H.C; healthy control, n.s; not 







Figure I-2. Pathogenic infection induced the secretion of WRS. (a) The levels of 
ARSs in the supernatants (SUP) and whole cell lysates (WCL) of Salmonella 
typhimurium (ST)-infected human PBMCs (MOI=1) for 2 hr were detected by Western 




of PBMCs following ST, E. coli, L. monocytogenes, S. aureus, and C. albicans 
(MOI=1) infection for 2 hr were measured by ELISA. (c) Secretion of WRS by virus 
infection. ELISA measurement of WRS in the cell culture supernatant of human 
PBMCs infected with respiratory syncytial virus (RSV) A2 or influenza A PR8 virus 
(both MOI=2) at the indicated time points. (d) The levels of LDH in ST-infected 
(MOI=1) or 1% TX-100-treated PBMCs were measured by LDH detection kit. (e) 
Mice were i.p. injected with indicated CFU of ST and the level of WRS in peritoneal 
lavage was measured by ELISA. Data are represented as mean ± SEM (n=5-11 for each 
time point). (f) The subsets of immune cells were isolated and infected with ST 
(MOI=1) for 2 hr. The levels of WRS in the cell culture supernatant were measured by 
ELISA. For panels b-f, the data are expressed as mean± SD of triplicate measurements.  
The statistical significance of the data (*p<0.05, **p<0.01, ***p<0.001) was 
determined against untreated control (b-f) (one-way ANOVA). For panels a, 






Figure I-3. WRS is promptly secreted prior to TNF-α upon Infection. (a) The 
levels of WRS, TNF-α, HMGB-1, HSP70, and β-actin in the supernant (SUP) and 




Western blot analysis. (b) The levels of WRS and TNF-α in cell culture SUP of 
ST-infected PBMC were measured by ELISA. (c) The mRNA levels of WRS and 
TNF-α in PBMCs infected with ST (MOI=1) at indicated time points were 
determined by real time-PCR (d) WRS secretion and expression during extension 
of ST infection. Secretions of WRS, GRS, and HRS were analyzed in the culture 
supernatant (SUP) and whole cell lysates (WCL) of ST-infected PBMCs (MOI=1) 
by Western blot analysis using each specific antibody. (e) The mRNA expressions 
of WRS and TNF-α were analyzed by real-time PCR at the indicated time points. 
For panels b, c and e, the data are expressed as mean± SD of triplicate 
measurements. The statistical significance of the data (*p<0.05, **p<0.01, 
***p<0.001) was determined against untreated control (b, c, e) (one-way 





Figure I-4. Endocytosis of pathogenic components affects WRS secretion. (a) 
The levels of WRS in the culture supernatants of PBMCs treated with increasing 
doses of Pam3CSK4, poly(I:C) LMW, poly(I:C), LPS (0.1-10 μg/mL), ST-FLA, 
imiquimod, ssRNA40, CPGODN (0.01-1 μg/mL), zymosan (0.1-10 μg/mL), 




1 μg/mL), H2O2 (0.01-1 mM), and nigericin (10-250 μM) for 2 hr were measured 
by ELISA. (b) PBMCs were treated with dynasore (1-100 μM) or cytochalasin D 
(1-100 μM) for 30 min before ST infection, and the levels of WRS in the cell 
culture supernatant were measured by ELISA. The data are expressed as mean± 
SD of triplicate measurements. The statistical significance of the data (*p<0.05, 
**p<0.01, ***p<0.001) was determined against untreated control (a) or ST-









Figure II-1. FL-WRS, but not mini-WRS, Induces Cytokine and Chemokine 
Productions (a) Protein array of cytokine/chemokine in culture supernatant of 
human PBMCs treated with PBS, FL-WRS (10 nM), and mini-WRS (100 nM) for 




analyzed using Image Lab 4.1 software. Experiments were performed in duplicate. 
PBMCs were treated with PBS, FL-WRS (10 nM), and mini-WRS (100 nM) for 3 
hr and (b) the levels of TNF-α, MIP-1α and MIP-1 in the cell culture supernatant 
and (c) mRNA were determined by ELISA and RT-PCR, respectively. (d) 
Cultured mouse primary immune cells (B, CD4+T, neutrophil, NK, monocyte and 
BMDM) were treated with FL-WRS (100 nM) for 18 hr and levels of TNF-α and 
MIP-1α in the cell culture supernatants were measured by ELISA. The relative 
secretion was calculated by comparing with that of control. (e) ELISA 
measurement of MIP-1α in the cell culture supernatant of BMDMs treated with 
FL-WRS (100 nM), mini-WRS (100 nM), and LPS (100 ng/ml) in the presence or 
absence of polymyxin B (50 μg/mL) for 18 hr. (f) ELISA measurement of MIP-1α 




mini-WRS (100 nM) isolated from HEK293T cells. For panels a, b, d, e and f, the 
data are expressed as mean± SD of triplicate measurements. The statistical 
significance of the data (*p<0.05, **p<0.01, ***p<0.001) was determined against 
untreated control (one-way ANOVA). For panels c, experiments were repeated 








Figure II-2.  FL-WRS increased the infiltration of phagocytes via 
macrophage activation. (a) Transwell migration assay. The number of migrated 
primary immune cells toward culture supernatants of FL-WRS-treated BMDMs 
was counted. (b) The infiltration of GFP-labelled neutrophils, monocytes and 




transgenic mice using in vivo imaging system. (c) Mice were i.p. injected with 
PBS, FL-WRS and mini-WRS (each 20 μg/mouse) for 4 hr and the number of 
PECs was analyzed by flow cytometry. (d) Splenocytes from macrophage-
depleted mice (MΦd) were treated with FL-WRS (100 nM) for 18 hr, and the 





 cells in splenocytes was analyzed by flow cytometry. (e) 
Macrophage-depleted mice were i.p. injected with FL-WRS (20 μg/mouse) for 4 






 cells in PECs were analyzed by 
flow cytometry. For panels a and d, data are represented as mean ± SD of 
triplicate measurements. For panels c and e, experiments are repeated two times 
independently and data are represented as mean ± SEM (n=10). The statistical 
significance of the data against each control was represented as *p<0.05, 
**p<0.01, ***p<0.001 (one-way ANOVA). For panels b, experiments were 





Figure II-3. FL-WRS increase phagocytosis via macrophage activation. (a) 
BMDMs were treated with PBS, FL-WRS (100 nM), and mini-WRS (100 nM) for 
18 hr. The incorporation of BrdU was detected using BrdU cell proliferation assay 




and CD86 in BMDMs treated with PBS, FL-WRS (100 nM), and mini-WRS (100 
nM) for 18 hr were determined by flow cytometry. (c) Alexa-labelled ST (red) 
was co-injected with PBS, FL-WRS, or mini-WRS into LysM-GFP transgenic 
mice ears. GFP-expressing cells that co-localized with red fluorescence were 
captured by in vivo imaging system at 2 hr following ST inoculation. The number 
of phagocytic cells was counted in 5 different fields and the percentage of 
phagocytic cells were calculated (>200 cells in each group). (d) BMDMs were 
treated with 100 nM of FL- and mini-WRS for 18 hr, then incubated with FITC-
labelled E. coli for 2 hr. Phagocytosis of the particles were measured by Vybrant 
phagocytosis assay kit. Data are represented as mean ± SD of triplicate 
measurements (a and d). *p<0.05, **p<0.01, ***p<0.001 compared with each 







Figure II-4. FL-WRS Protects Bacteria-Infected Mice from Lethality. (a) 
Experimental scheme. The mice were i.p. injected with PBS, mFL-WRS, or 
mΔ51-WRS (each 20 μg/mouse) at 5 min after peritoneal Salmonella typhimurium 
(ST) inoculation (1x10
7




forming unit. (b) Mice (n=10) were inoculated with FITC-labelled ST for 2 hr, 
and the percentage of peritoneal Ly6G
+
 neutrophils were analyzed by flow 
cytometry (c) Bacterial load (n=6-10) and (d) IHC against ST in spleen and liver 
of mice at 4 hr after ST inoculation. Arrows indicate ST. (e) Survival rates of ST-
infected mice (n=10) treated with PBS, mFL-WRS (pink) and mΔN51-WRS 
(blue). Data are represented as mean ± SEM (b and c) or mean (e). *p<0.05, 













Figure II-5. Neutralization of FL-WRS aggravates bacterial infection (a) A 
phage-displayed scFv library was panned against surface-immobilized N154. 
After panning, the output clones were screened by ELISA for their binding to 




scFv antibodies were measured. Pre-mixed scFvs (10 μg/mL) and FL-WRS (30 
nM) were treated in PMA-differentiated THP-1 cells for 3 hr. The levels of TNF-α 
were measured by ELISA. (b) Western blot analysis of recombinant human FL-
WRS and mini-WRS using anti-WRS scFv 4G1. Experiments were performed in 
duplicate. (c) Neutralization of scFv 4G1 against FL-WRS reduced TNF-α 
production in PMA-differentiated THP-1 cells. FL-WRS (30 nM) and/or scFv 
4G1 (5 μg/mL) were incubated for 2 hr at room temperature and treated for 3 hr. 
The levels of TNF-α were measured by ELISA. Neutralization of scFv 2B against 
FL-WRS did not affect TNF-α production (d) Experimental scheme. The mice 
were injected with PBS, mFL-WRS, or mΔ51-WRS (each 20 μg/mouse) and then 
Salmonella typhimurium (ST, 1x10
7
 CFU) were i.p. injected. (e) The levels of 
TNF-α and MIP-1α and (h) the number of PECs expressing Ly6G
+




peritoneal exudates were determined by ELISA and flow cytometry, respectively. 
(f) Survival rates of ST-infected mice (n=10) treated with PBS, scFv 4G1 (pink), 
or scFv 2B (blue). The uninfected mice (n=10) treated with 4G1 alone were used 
as the negative control (orange). Data are represented as mean ± SEM (e, f, and g) 
or mean (a and c). *p<0.05, **p<0.01, ***p<0.001 compared with each control 






Figure III-1. Immune Activation Mechanism of FL-WRS via TLR4-MD2. (a) 
HEK293 cells expressing various PRRs and NF-κB SEAP reporter system were 
treated with FL-WRS (100 nM) for 18 hr. The relative activity of alkaline 
phosphatase was calculated by comparing that of cells treated with each positive 





cells treated with FL-WRS and mini- WRS for 30 min. YY-1 and β-actin were 
used as loading controls of nucleus and cytoplasm, respectively. (c) TLRs were 
silenced in BMDMs using their respective siRNAs for 48 hr followed by FL-WRS 
(100 nM) treatment for 18 hr. The levels of TNF-α and MIP-1α in the culture 
supernatants were measured by ELISA. Scramble siRNA was used as a negative 










mice were treated with FL-WRS (100 nM) and PBS for 18 hr. Levels of MIP-1α 
and TNF-α in the cell culture supernatant were measured by ELISA and (e) 
phagocytosis of FITC-labelled E. coli for 2 hr was determined by Vybrant 






mice (n=10) were i.p. 
injected with FL- , and the number of Ly6G
+
 
neutrophils in the PECs was determined by flow cytometry. For panels a, c, and d, 
data are represented as mean ± SD of triplicate measurements with *p<0.05, 
**p<0.01, ***p<0.001 (one-way ANOVA). For panels e and f, data are 







mice (one-way ANOVA). For panels b, e, and f, 





















Figure III-2. Binding of FL-WRS, mini-WRS and N-terminal Peptides to 
TLR4 and MD2 (a) GST pull-down assay. GST-tagged FL-WRS or mini-WRS 
were pre-incubated with H is-tagged MD2, and then TLR4 (2 μg each) was added. 
(b) Schematic diagram of FL-WRS, mini-WRS and series of N-terminal peptides. 




TNF-α and MIP-1α were measured by ELISA in the culture supernatants of 
BMDMs treated with FL-WRS, mini-WRS, and series of N-terminal peptides 
(100 nM each) for 18 hr. (d) Activation of NF-κB signaling by N154. J774A.1 
cells were treated with N154 for 30 min and the levels of various proteins 
involved in NF-kB activation were detected by western blot analysis. In the right 
panel, BMDMs were transfected with each indicated siRNA for 48 hr and then 
treated with N154 (100 nM) for 18 hr. (e) FL-WRS or mini-WRS was embedded 
on the chip and MD2 (1.5, 0.75, 0.37, 0.19, and 0.09 μM) was flowed over as an 
analyte. TLR4 was embedded on the chip and (f) FL-WRS or mini-WRS (3, 1.5, 
0.75, and 0.37 μM) was flowed over as an analyte. MD2 was embedded on the 
chip and (g) N47, N65, N115, N125, N135, N145, and N154 (3, 1.5, 0.75, and 
0.37 μM) were flowed over as analytes. TLR4 was embedded on the chip and (h) 
N47, N65, N115, N125, N135, N145, and N154 (3, 1.5, 0.75, and 0.37 μM) were 
flowed over as analytes. (i) Summary of SPR analysis for binding activities of N-
terminal peptides with TLR4 or MD2. For panels c and d, data are represented as 
mean ± SD of triplicate samples with the statistical significance of *p<0.05, 










Putative binding model of TLR4-MD2 with WRS homodimer based on protein-
protein docking study (a) The crystal structure of FL-WRS (PDB code 1R6T) 
monomer. The structural information of N1-6 aa and 61-81 aa peptides are 
missing. The helix-turn-helix WHEP domain spanning 8-64 aa is shown in red. (b) 
Potential complex formation between TLR4-MD2 (blue and grey, respectively, 
PDB code 3FXI) and WRS monomer (yellow). The peptide region spanning 
WHEP domain (red) is predicted to make interactions with both TLR4 and MD2. 
(c) Based on the model, TLR4-MD2 dimerization can be facilitated by bivalent 
interaction of the N154 peptides to two TLR4-MD2 units (blue and green) in trans. 
The two TLR4 interaction sites in N154 are shown (red) in ribbon type 
presentation. (d) The complex structure of the 2:2:2 TLR4-MD2-WRS is 




WRS and TLR4-MD2. The levels of TNF-α and MIP-1α were measured by 
ELISA in the culture supernatants of BMDMs treated with WRS mutants (100 nM) 
for 18 hr. (f) Cartoon illustration explains how FL-WRS and N154 can activate 
TLR4-MD2 but not N65 (WHEP) and mini-WRS homodimer, based on modeling 
studies and functional analysis results. For panels e, data are represented as mean 
± SD of triplicate samples with the statistical significance of *p<0.05, **p<0.01, 








Table 1. Comparative distributions of sepsis-causing pathogens.  
Gram(-) bacteria  N Gram(+) bacteria  N 
Acinetobacter baumanii 1 Enterococcus faecalis  2 
Acinetobacter baumanii (CRAB) 7 Enterococcus faecalis (VRE) 1 




Aeromona hydrophila 3 Staphylococcus aureus (MSSA) 3 
Burkholderia cepacia  2 Staphylococcus epidermidis  1 
Enterobacter aerogenes  1 Streptococcus pneumoniae  3 
Enterobacter cloacae  1 Streptococcus agalactiae  1 
Escherichia coli  21 
Haemophilus Influenza 1 
Klebsiella pneumonia  13 
Morganella morganii  1 
Proteus mirabilis 1 
Stenotrophomonas maltophilia 1 
Pseudomonas aeruginosa (CRPA) 1 
Pseudomonas fluorescens  4 





  Fungi N Multi-infection N 
Candida albican 2 CRAB, E. coli 1 







Aspergillus 3 K. pneumonia,  E. coli 1 
  












MRSA, A. baumanii 1 
 








 Fungus + MRSA 1 
 
 unknown 3 
The frequencies of Gram-negative, Gram-positive, fungi, multi-infection, and 




Table 2. Gene specific primer sequences for qRT-PCR and RT-PCR. 
  Gene Name Oligonucleotide Sequence 
qRT-
PCR 
hTNF-α-F 5’-GGAGAAGGGTGACCGACTCA-3’  
hTNF-α-R 5’-CTGCCCAGACTCGGCAA-3’  
hWRS-F 5’-AAGAATTCATGCCCAACAGTGAGCCC-3’ 
hWRS-R 5’-AACTCGAGCTACCCTGGAGGACAGTCAGCCTT-3’ 
human β-actin-F 5′- CATGTACGTTGCTATCCAGGC-3′ 







hTNF-α  primer kit (Bioneer Corp., Daejeon, Republic of Korea) 
Human β-actin-F 5′-CATGTACGTTGCTATCCAGGC-3′ 










mouse β-actin-F 5′-ACCGTGAAAAGATGACCCAG-3′ 











Discussion   
 
Human immune system has developed multi-layered mechanisms through 
evolutionary processes to win the battle against microbial infection. The first-line 
immune defense directly destroys invading pathogens within minutes, but if it 
fails, innate immune cellular responses are activated. Although exogenous ligands 
specific to different TLRs are well determined (Takeuchi and Akira, 2010), an 
infection-specific endogenous TLR activator has not yet been determined in 
human. This work provides several evidences suggesting human FL-WRS as a 
novel endogenous ligand of TLR4, promptly alerting innate immunity against 




infectious agents (Figure II-1), rather than indirectly triggered by pro-
inflammatory stimuli. It is supported by the fact that WRS secretion into the blood 
is specifically observed in patients with sepsis but not with SIRS and chronic 
status of autoimmune diseases (Figure I-1). In contrast, extracellular release of 
HMGB-1 occurs not only by infection (Wang et al., 1999), but also by various 
inflammatory disorders (Harris et al., 2012) and HSP70 is induced by SIRS 
regardless of infection (Sonna et al., 2010) . Second, FL-WRS promptly responds 
to pathogens prior to onset of innate immune responses. Since FL-WRS is 
constitutively present in cells, it can be immediately released from monocytes, 
which are the first responding cells to infection, without de novo synthesis that is 




Third, FL-WRS secretion can be induced by diverse pathogens (Figure I-3 and II-
1), which could provide immunological flexibility. Fourth, FL-WRS appears to 
work primarily via TLR4 and possibly via TLR2. Through these receptors, FL-
WRS could simultaneously sensitize strong and diverse immunological responses 
(Sato et al., 2000). Fifth, FL-WRS primarily elicits its action to macrophages. As a 
result, FL-WRS may not only increase phagocytosis in situ but also clear 
pathogens by enhancing neutrophil infiltration via chemokines. With these 
features, FL-WRS appears to suppress the propagation of infected pathogens at 
early stage while priming innate immune responses.  
It is intriguing that both of FL-WRS and mini-WRS could bind to TLR4-MD2 




N-terminal 47 aa that is lacking in mini-WRS may be necessary for the right 
orientation of the TLR4-MD2 dimers that is required for the activation of 
downstream signal pathways. In fact, N47 forms a part of WHEP domain existing 
in the structures of several different ARSs and it is implicated in the modulation of 
various protein-protein interactions and immune reactions(Guo et al., 2010). The 
binding model and mutational analysis also explain why the peptides containing a 
partial or full WHEP domain of WRS (N47, N65) are not active despite the fact 
that they could bind to both of TLR4 and MD2. The bivalent ability of the N154 
interacting two TLR4-MD2 complexes (via the WHEP domain and addition site in 
downstream) in trans appears to be necessary to work as the active ligand. It is not 




work as the fully functional ligand. One possibility is that N154 can secure its 
presence as a defense factor by being connected to WRS that is indispensable for 
cell viability. Another possibility is that the catalytic domain of WRS can also 
play an additional role in the immunological responses against infection.    
Although mini-WRS was inactive in innate immunity, it was previously shown 
to play potent anti-angiogenic activity upon secretion. In this case, N47 needs to 
be cleaved off in order to expose the active site cleft of WRS to the protuberant 
tryptophan present in the ligand-binding domain of VE-cadherin, the functional 
receptor of mini-WRS (Zhou et al., 2010). However, the active role of FL-WRS 
and its N-terminal peptide itself has not been reported yet and here I found its 




activity of the N-terminal truncated mini-WRS would be necessary to prevent 
chronic inflammation that may be caused by the sustained secretion of FL-WRS. 
At this point, it is not clear whether FL-WRS would work as it is or it is cleaved 
to generate the N154 peptide, which then activates TLR4 signal at physiological 
situation. N154 contains WHEP domain in its N-terminal end and this domain 
plays a crucial role in the binding to TLR4-MD2. Since several different ARSs 
also contain WHEP domains in their structures, it would be interesting to see 
whether other ARSs could do similar function as WRS. In this regard, it is worth 
noting that WRS is specifically secreted out to serum in the infected patients 
although GRS also contains WHEP domain, a conserved domain of helix-turn-




It is not clear at this moment whether FL-WRS should be considered as a new 
component of innate immunity or as a distinct defensive mechanism that would 
prime innate immunity at the early stage of infection. Considering that FL-WRS 
uses TLR4 as a functional receptor, it can be recognized as an extension of innate 
immunity. However, FL-WRS can be considered as a unique defense factor 
recruited from protein synthesis machinery. It would be interesting to investigate 
whether the catalytic activity of WRS would be involved in its extracellular 
activity. In any case, this work first reports the functional connection of a protein 
synthesis enzyme to host defense mechanism against infection. This finding also 
suggests that WRS can be used as an early biomarker and also as an immune 




Conclusion and Perspectives 
 
The N-terminal truncated form of a protein synthesis enzyme, tryptophanyl-tRNA 
synthetase (mini-WRS) is secreted as an angiostatic ligand. However, the 
secretion and function of the full-length WRS (FL-WRS) remain unknown. Here 
we report that the FL-WRS, but not mini-WRS, is rapidly secreted upon pathogen 
infection to prime innate immunity. Blood levels of FL-WRS were increased in 
the sepsis patients, but not in those with sterile inflammation. FL-WRS was 
secreted from monocytes and directly bound to macrophages via toll-like receptor 
4 (TLR4)-myeloid differentiation factor 2 (MD2) complex to induce phagocytosis 




Typhimurium–infected mice reduced the bacteria and improved mouse survival, 
whereas its titration with the specific antibody aggravated the infection. The N-
terminal 154 amino acid eukaryote-specific peptide of WRS was sufficient to 
recapitulate FL-WRS activity and its interaction mode with TLR4-MD2 is 
suggested. Based on these results, secretion of FL-WRS appears to work as a 
primary defense system against infection, acting prior to full activation of innate 
immunity.  
In this study, I investigate an active role of FL-WRS, not mini-WRS, as an 
endogenous activator of TLR4. However, it is possible that the anti-angiogenic 
activity of the N-terminal truncated mini-WRS serves as a feedback mechanism 
to prevent chronic inflammation that may be caused by the sustained secretion of 
FL-WRS. The early secretion of FL-WRS (starting 15 min post-infection and 




of infections such as sepsis. Moreover, injection of FL-WRS led to pathogen 
clearance and improved survival in infected mice, suggesting that FL-WRS or its 
eukaryotic-specific N-terminal peptide could be developed as a novel therapeutic 
agent against diverse pathogenic challenges.  
 
Materials and Methods 
 
Human Samples 
Serum samples were collected from 20 healthy controls, 108 septic patients 
receiving intensive care for sepsis, and 25 SIRS patients without infection. All 
patients had been admitted to the ICU of a university-affiliated hospital in 
Republic of Korea and only patients with proven bacterial and fungal infection 




ACCP/SCCM Consensus Conference in 1992(Bone et al., 1992). This study was 
approved by the Institutional Review Board of the Asan Medical Hospital (2011-
0001). 
Total 52 subjects, who were admitted to the Severance Hospital Allergy-
Asthma Clinics from January 2014 to July 2015, were enrolled. The enrolled 
subjects included 22 healthy control and 30 stable asthma patients who were 
diagnosed as asthma by allergy specialists, based on their symptoms and 
pulmonary function test results (>12% increase of forced expiratory volume for 1 
second (FEV1) after bronchodilator use. This clinical study was approved by the 
Institutional Review Board, Severance Hospital and Yonsei University Health 
System (approval number: 4-2013-0397).  




patients with rheumatoid arthritis (RA) and 15 healthy controls. Primary Sjogren’s 
syndrome was diagnosed according to the American-European Consensus Group 
criteria for primary Sjogren’s syndrome(Vitali et al., 2002) or the 2012 American 
College of Rheumatology criteria(Shiboski et al., 2012). RA was diagnosed 
according to 1987 revised criteria for the classification of rheumatoid 
arthritis(Arnett et al., 1988) or 2010 rheumatoid arthritis classification 
criteria(Aletaha et al., 2010). This study was approved by the Institutional Review 
Board of Seoul St. Mary’s Hospital (KC13ONMI0646). All human serums were 
obtained under informed consent.   
 
Reagents and Assay Kits 




4872), anti-NF-κBp65 (Cat. No 3034), anti-p-IκB-α (Cat. No 9246), anti-p-ERK 
(Cat. No 9101), anti-ERK (Cat. No 9102), and anti-His-tag (Cat. No 12689) were 
purchased from Cell Signaling Technology. Anti-CD11b-FITC (M1/70, Cat. No 
553310), anti-LY6G and Ly6C-PE (RB6-8C5, Cat. No 553128), CD40-PE (3/23, 
Cat. No 553791), CD80-PE (16-10A1, Cat. No 553769), and CD86-FITC (GL1, 
Cat. No 553691) were from BD Pharmingen. Anti-F4/80-PE (BM8, eBioscience, 
Cat. No 12-4801-80), TLR4 (R&D systems, Cat. No 1478-TR) and MD2 
recombinant proteins (R&D systems, Cat. No 1787-MD) were also purchased. 
Anti-WRS (Cat. No NMS-01-0009,), anti-MRS (NMS-01-0003), anti-HRS(Park 
et al., 2005), anti-GRS (NMS-01-0014), anti-KRS (NMS-02-0005), anti-DRS 
(NMS-01-0013) and anti-AIMP1 (NMS-01-0019) antibody were purchased from 




Signaling Technology, Cat. No 6813), Lactate dehydrogenase (LDH) cytotoxicity 
detection kit (Takara, Cat No MK401), Vybrant phagocytosis assay kit (Cat. No 
V6694), ELISA kits for human WRS (Cusabio, Cat. No CSB-E11789h), GRS 
(Cusabio, Cat. No CSB-EL009262hu), KRS (MyBiosource, Cat. No MBS067424), 
murine WRS (Cloud Clone Corp, Cat. No SEB748mu), human HMGB-1 (Cloud 
Clone Corp, Cat. No SEA399hu), human HSP70 (Cloud Clone Corp, Cat. No 
SED506hu), human MIP-1α (R&D systems, Cat. No DY270), human MIP-1β 
(R&D systems, Cat. No DY271), human TNF-α (eBioscience, Cat. No 88-7346-
88), murine MIP-1α (R&D systems, Cat. No DY150), murine MCP-1 (R&D 
systems, Cat. No DY479), and murine TNF-α (eBioscience, Cat. No 88-7324-88) 
were purchased. Each assay was performed according to manufacturer’s protocol. 




Cat. No Z4250), human TNF-α Peprotech, Cat. No 300-01A), nigericin (Sigma, 
Cat. No N7143), cytochalacin D (Sigma, Cat. No C2618), dynasore (Sigma, Cat. 
No D7693), and polystyrene latex beads (Sigma, LB30) were purchased. Dr. 
Honggu Chun (Korea University, Republic of Korea) kindly provided liposome 
(200 nm size). 
 
Bacteria, Fungus, and Virus 
Salmonella typhimurium (ATCC 14028), Listeria monocytogenes (ATCC 15313), 
Escherichia coli-K12 (ATCC 10798), Staphylococcus aureus (ATCC 25923), and 
Candida albicans (ATCC 10231) were obtained from Korean Culture Center of 
Microorganisms (Seoul, Republic of Korea). The number of overnight cultured 




predetermined calibration curve. Respiratory syncytia virus(RSV) A2 virus was 
propagated by inoculating with human larynx carcinoma cell line, HEp-2 (CCL-
23), monolayer with a previously prepared small-scale isolate stock (MOI=0.01) 
and harvested when cytopathic effects were greater than 60%. Influenza A/Puerto 
Rico/8/1934 virus was propagated in specific pathogen-free embryonated eggs. 
Viruses were titrated by standard plaque assay.  
 
Cell Culture 
Human PBMCs were isolated by Cell Preparation Tube with sodium citrate 
(Becton Dickinson, Cat. No 362761). The human bloods were obtained from 
healthy volunteers and the protocol was approved by the Institutional Review 




(Cat. No 130-101-638), T (Cat. No 130-096-olp; 535), NK (Cat. No 130-092-657), 
and monocyte (Cat. No 130-091-153) were prepared from human PBMC using 
magnetic activated cell sorting (MACS, Miltenyi Biotec). Mouse B (Cat. No 130-
090-862) and T cells (Cat. No 130-090-860) were prepared from mouse spleen. 
Mouse NK cells (Cat. No 130-096-892), monocyte (Cat. No 130-100-629) and 
neutrophil (Cat. No 130-097-658) were prepared from MACS. BMDMs were 
differentiated from mouse bone marrow cells for 6-7 days with M-CSF (Peprotech, 
Cat. No 315-02, 20 ng/mL). All isolated and cultured cells were determined by 
cell surface marker expression using FACS analysis. 









) and J774A.1 (murine 








Culture Collection (Manassas, VA, USA). The HEK293T and J774A.1 cells were 
grown in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% fetal 
bovine serum (FBS) and 1% streptomycin and penicillin. THP-1 cell lines were 
grown in RPMI-1640 medium containing 10% fetal bovine serum (FBS), 1% 
streptomycin and penicillin, and 50 μM β-mercaptoethanol. Mycoplasma 
contamination was tested by commercially available mycoplasma detection kit 
(Takara, Cat. No 6601). 
 
ELISA 
The levels of WRS, GRS, KRS, HMGB1, HSP70, TNF-α, MIP-1α, MIP-1β, and 
MCP-1in the cell culture supernatants, peritoneal exudates lavage, and human 






WRS protein precipitation by TCA  
Human PBMCs (2X10^6/mL) were seeded in 60pi dish in RPMI media 
containing 1~2% FBS for 2hrs. S. typhimurium, suspended in serum free media, 
was added in the cultured hPBMCs. The culture media was collected and 
centrifuged at 500Xg, 4℃ for 10min. And then collected the supernant was re-
centrifuged at 10,000Xg, 4℃ for 10min. 100μL of 100% TCA solution was 
added into 900μL supernant to make 10% of total volume and incubated the tube 
in 4 ℃ over-night. After one day from 4 ℃ incubation, centrifuge the tube at 




pH8.0 100mM HEPES and 50-60 ㎕ 5Xsds sample loading dye into the tube. 
Boil the sample for 15min and load the gel for Western blot. 
 
Western Blot Analysis 
Cytosolic and nuclear extracts were prepared using a Nuclear Extract kit (Active 
Motif, Cat. No 40010), and Western blot analysis was performed according to the 
methods previously described (Park et al., 2014) using specific antibodies. 
 
Recombinant Protein Purification 
A series of human WRSs, N-terminal peptides, mutant WRSs, murine FL-WRS 
(mFL-WRS), and the N-terminal 51aa-deleted WRS (mΔN51-WRS) were cloned 




mutagenesis kit (Agilent Technologies). The recombinant proteins were 
overexpressed in E. coli Rosetta2 (DE3) strain. The bacterial cells were lysed by 
sonication 3 times (10 sec duration with 50 sec interval). His-tagged proteins in 
supernatants were purified using HiTrap HP column (GE Healthcare), followed by 
HiLoad 16/600 Superdex 200 prep grade column (GE Healthcare Life Sciences). 
GST-tagged proteins were purified by Glutathione-Sepharose high performance 
beads (GE Healthcare Life Sciences). Purified proteins were filtered using 
Mustang E membrane (Pall Corporation). For preparation of the recombinant 
proteins from HEK293T cells, human FL-WRS and mini-WRS were cloned into 
pEXPR-IBA42 vector (IBA, Cat. No 2-1942-000) designed for the expression in 
cell culture supernatant. FL-WRS and mini-WRS were expressed in HEK293T 






RT-PCR and Real Time-PCR 
RNAs were extracted according to the protocol of the RNeasy kit (Qiagen, Cat. 
No 74104), and the RNA samples were used for cDNA synthesis using a 
PrimeScript RT reagent kit (TaKaRa, Cat. No PR037A). Quantitative RT-PCR 
was quantified using 7500 real-time PCR system (Applied Biosystems) with 
Power SYBR
®
 Green PCR Master Mix (Applied Biosystems, Cat. No 4367659). 
The mRNA level of GAPDH and β-actin were used as internal control. RT-PCR 
was performed according to the methods previously described(Park et al., 2014). 





Cell Migration Assay 
The cell migration assay was performed using polycarbonate membrane transwell 
(Costar, Cat. No 3421, 5.0 μm,) coated with gelatin. Mouse primary cells were 
allowed to migrate for 4 hr into lower chamber and infiltrated cells were counted 
under the bright field microscope.  
 
Animal Experiments 
Animal experiments complied with the guidelines of the Daejeon University 
Animal Care and Use Committee (approval number DJUARB2014-031). 
C57BL/6 mice (female, 9-10 weeks old) were purchased from Daehan Biolink Co. 
Ltd. (Chungbuk, Republic of Korea). Female LysM-GFP mice (Lysozyme M-GFP, 




between 12 and 17 weeks for in vivo imaging experiments. MD2
-/-
 mice(Nagai et 
al., 2002) were purchased from RIKEN BioResource Center (Ibaraki, Japan). Dr. 




 mice(Hoshino et 
al., 1999; Takeuchi et al., 2000). Sample size (the number of mice per group) was 
chosen to warrant statistical significance (generally >5 mice per group) and mice 
were randomly distributed into their respective groups. All experiments were 
conducted without blinding with age and sex-matched mice. The counting of 
phagocytic cells in pictures obtained from in vivo imaging experiments were 
performed in a blind manner. We included all of the tested mice for analysis. The 
samples from each mouse were prepared as duplicate or triplicate for 





In Vivo Bacterial Infection and Bacteria Counting 
Salmonella typhimurium (ST) was grown to OD600=0.5 in NB broth, washed in 
PBS at 10,000 xg and resuspended in PBS. ST was intraperitoneally infected with 
1x10
7
 CFU per mouse. After 4 hr infection, spleen and liver were homogenized in 
4 mL of D.W. The homogenized lysates were serially diluted to 1:10 with D.W. 
10 μL of chosen dilutions were spotted four times on NB agar plates and 
incubated at 37°C. 
 
FITC labeling of Bacteria 
Bacterial cells were harvested by centrifugation at 10,000x g and 4°C for 5 min 
and washed with PBS for two times. Measure the optical density at 600 nm of cell 
suspension and prepare 10
9




Invitrogen F-1906) was freshly dissolved with DMSO to make 10mg/mL stock 
solution. Dilute the FITC stock solution of 10 mg/ml to a final concentration of 
0.2 mg/ml in PBS. Add 1 ml of FITC (0.2 mg/ml) solution to the microcentrifuge 
tube, thoroughly resuspend the bacterial pellet, and incubate for 30 min at 4◦C in 
the dark. Resuspend the bacteria to the desired concentration in sterile PBS and 
use for the infection. 
 
Lavaging the peritoneal exudate cells (PECs) 
The peritoneal cavity is lavaged 0 to 4 h after injection of WRS protein. Mice 
were sacrificed using carbon dioxide. Make a small (0.5 cm) incision along the 
midline of the abdomen allowing the skin to be pulled back to expose the 




syringe and 5/8-inch 25-G needle. Gently massage the mouse abdomen with the 
length of a 2-inch 19-G needle to ensure that cells that are loosely adherent to the 
peritoneal wall or other organs will detach and become suspended in the lavage 
fluid. Use a 19-G needle to gently and slowly extract the lavage fluid from the 
peritoneal cavity. Transfer the fluid to a 15-ml centrifuge tube and keep on ice.  
 
Preparation of WRS and GRS scFv  
Phage-displayed human scFv library was panned against different recombinant 
human WRS as described previously(Yang et al., 2009). Briefly, an immunotube 
was coated with 10 μg of WRS and blocked with mPBS (PBS with 3% nonfat 
dried milk). Phage-displayed scFv library (1x 10
13
 CFU) in 1 mL of mPBST 
(PBST with 3% nonfat dried milk) was added to the immunotube. After 2 hr 




eluted with 1 mL of 100 mM trimethylamine and neutralized with 0.5 mL of 1 M 
Tris-HCl (pH 7.0). ER2537 E.coli in mid-log phase were infected with the eluted 
phage, and plated on LB-ampicillin plates supplemented with 2% glucose. Next 
day, the bacteria were collected from the plates by adding 5 mL of LB medium to 
the plate and scraping the bacteria with glass spreader. Fifty microliters of the 
harvested bacteria were added to 20 mL SB (3% Tryptone, 2% yeast extract, 1% 
MOPS, pH 7.0) plus ampicillin medium and grown for 2-3 hr until OD600 reaches 
0.5. VCSM13 helper phage (1x10
11
 PFU) was added, and the infection continued 
for 1 hr at 37
o
C with slow shaking. Kanamycin (70 μg/mL) was subsequently 
added, and the culture was incubated overnight at 30
o
C with vigorous shaking. 
Next day, the culture was centrifuged, and phage precipitation solution (4% 




After incubation on ice for 30 min, the precipitated phages were obtained by 
centrifugation and suspended in PBS, and used for the subsequent round of 
panning. After four rounds of panning the library, individual scFv clones were 
screened by ELISA for their ability to bind WRS. The positive clones were 
sequenced to identify unique clones, and each clone was expressed in E.coli, and 
purified by Ni-NTA affinity column. Anti-GRS scFv clone 2B had been isolated 
form the same synthetic scFv library as scFv 4G1 using recombinant human GRS 
as an antigen. The clone specifically bound to GRS in immunoblot assays.  
 
In Vivo Imaging System and Image Processing 
The Alexa647-labelled FL-WRS, mini-WRS (red fluorescence, each 0.1 μg) or 




mice. The infiltration of green fluorescence-labelled cells was monitored using in 
vivo imaging system. Time lapse imaging was performed with 30 sec intervals at 1 
or 4 hr after injection (20 x magnifications). For analysis of increased 
phagocytosis by FL-WRS, Alexa647-labelled Salmonella typhimurium (ST) (red) 
was co-injected with PBS, FL-WRS, or mini-WRS into LysM-GFP transgenic 
mice ears. GFP-expressing cells that co-localized with red fluorescence were 
captured by in vivo imaging system at 2 hr following ST inoculation. The number 
of phagocytic cells was counted in 5 different fields and the percentage of 
phagocytic cells was calculated (>200 cells in each group). A custom-built video-
rate laser-scanning confocal microscope imaging system modified from a 
previously designed system(Choe et al., 2013; Faust et al., 2000; Seo et al., 2015) 




wavelength was at 488 nm (MLD, Cobolt), 561 nm (Jive, Cobolt) and 640 nm 
(MLD, Cobolt) was used as fluorescent excitation source to achieve three-color 
fluorescent image. Fast-rotating 36 facet polygonal mirror (MC-5, aluminum 
coated, Lincoln Laser) and galvanometer mirror (Cambridge Technology, 6230H) 
were utilized to obtain 2D scanning pattern. Emitted three color fluorescent 
signals from intravital mouse model on 3D motorized XYZ translational stage 
(Sutter Instrument, MPC-200-ROE) were detected by high-sensitive 
photomultiplier tubes (Hamamatsu, R9110) and digitalized by 8-bit 3-channel 
frame grabber (Matrox, Solios). 20x (Olympus, LUMFLN60XW, NA1.1), and 
60x objective lens (Olympus, LUCPLFLN20X, NA0.45) objective lens generated 
500x500, and 167x167 μm images of field views, respectively. Images were 




software with 512x512 pixels per frame at 30 Hz of frame rate, and processed by 
Matlab (Mathworks) for XY-shift compensation and by ImageJ software (National 
Institutes of Health) for XZ/YZ axis-reconstruction.  
 
Flow Cytometry 
The cells were stained with antibodies for 30 min on ice in a binding buffer (PBS 
with 0.5% BSA and 0.01% NaN3) and analyzed by one- or two-color flow 




Paraffin embedded sections were incubated in a solution of 0.3% H2O2 for 15 min 




RT with primary antibodies (1:2000 diluted) against Salmonella antibody (Novus 
Biologicals, Cat. No NB600-1087). The detection systems EnVision+ for rabbit 
antibodies (DAKO, Glostrup, Denmark, Cat. No K4003,) were applied according 
to the manufacturers' instructions. Slides were stained with liquid 
diaminobenzidine tetrahydrochloride (DAB+), a high-sensitivity substrate-
chromogen system (K3468, DAKO, Glostrup, Denmark). Counterstaining was 
performed with Meyer's haematoxylin. The images on the slides were visualized 
with an Olympus Bx40 light microscope. 
 
Macrophage Depletion  
To deplete macrophages in spleen, mice were injected i.v. with liposomal 




macrophages in PECs, mice were simultaneously injected both i.v. (0.5 mg/mouse) 
and i.p. (0.75 mg/mouse) with liposomal clodronate for 24 hr. Control liposome 
was injected as a negative control of macrophage depletion.  
 
PRRs Reporter Assay 
HEK293 cells expressing the SEAP reporter system (Invivogen) were treated with 
FL-WRS or each specific ligand (positive control) for mouse PRRs for 18 hr 
(InvivoGen Study # 157908). The ligands are HKLM (heat-killed L. 
monocytogenes, 1x10
8
 cells/mL), poly(I:C) (1 μg/mL), E. coli-K12 LPS (100 
ng/mL), S. typhimurium flagellin (ST-FLA, 100 ng/mL), CL097 (1 μg/mL), 
CL075 (10 μg/mL) + poly(dT) (10 μM), CpG ODN 1826 (100 ng/mL), C12-




cerevisiae, 10 μg/mL). 
 
Si-RNA Transfection 
Mouse si-TLR1 (Cat. No Tlr1-MSS211916), si-TLR2 (Cat. No Tlr2-MSS216272), 
si-TLR4 (Cat. No Tlr-MSS211922), si-TLR5 (Cat. No Tlr5-MSS285031), si-
TLR6 (Cat. No Tlr6-MSS211925) and si-MD2 (Cat. No Ly96-MSS275499) were 
purchased from Invitrogen. BMDMs (1x10
5
) were plated in 48-well for overnight 
and transfected with si-RNAs using X-tremeGENE siRNA Transfection Reagent 
(Roche Diagnostics, Cat. No 04 476 093 001). Stealth universal RNAi (Invitrogen) 
was used as a negative control.  
 




FL-WRS and mini-WRS were cloned into pGEX4T-1 (GST-tag) vector. The 
recombinant proteins were overexpressed in E. coli Rosetta2 (DE3) strain. The 
bacterial cells were lysed by sonication 3 times (10 sec duration with 50 sec 
interval). GST-tagged WRSs were purified by Glutathione-Sepharose high 
performance beads (GE Healthcare Life Sciences). Purified proteins were filtered 
using Mustang E membrane (Pall Corporation). GST, GST-FL-WRS, or GST-
mini-WRS (each 2 μg) in PBS were mixed with Glutathione-Sepharose beads at 
4°C for 2 hr. Recombinant human TLR4 and/or MD2 (each 2 μg) proteins were 
added and the mixtures were incubated at 4°C for 4 hr. Proteins binding to beads 
were subjected to Western blot analysis. 
 




Surface Plasmon Resonance (SPR) experiments were performed using a Biacore 
T200 (GE Healthcare) equipped with a Series S sensor chip CM5 (GE Healthcare) 
at 25°C. PBS buffer (KH2PO4 144 mg/L, NaCl 9,000 mg/L, Na2HPO4 795 mg/L, 
without calcium or magnesium) was used as a running buffer for the 
immobilization procedure. Immobilization was performed by using amine 
coupling kit (GE Healthcare). Flow cells were activated with a 7 min pulse of a 
1:1 mixture of EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride) and NHS (N-Hydroxysuccinimide) according to manufacturer’s 
recommendations. FL-WRS and mini-WRS were diluted with 10 mM sodium 
acetate (pH 5.0 for FL-WRS and pH 5.5 for mini-WRS) and immobilized to a 
Series S sensor chip CM5 to achieve immobilization levels of 600-1600 and 600-




proteins were diluted with 10 mM sodium acetate (pH 5.0) and immobilized to the 
chip giving a surface density of 1000-2600 and 600-1000 response units (Shen et 
al.), respectively. Flow cells were then blocked with a 7 min pulse of 1 M 
ethanolamine-HCl (pH 8.5). Serially diluted analytes or buffer were injected for 
1-10 min at 30 µL/min flow rate and washed out for 20 min according to the 
analytes. Sensorgrams obtained with the reference channel were subtracted from 
those obtained with the channel with each protein. 
 
Protein-protein Docking Study 
Interaction of WRS and TLR4-MD2 of human form was simulated by using 
ZDOCK and RDOCK in the Discovery Studio 4.5 software package. The X-ray 




Protein Data Bank. Also, TLR4-MD2 complex X-ray structure was (PDB code 
3FXI) from the PDB site. To assignment CHARMM force field for protein-
protein docking study, I modified selenomethionine (Mse) residue of WRS to 
methionine (Met) using Build Mutant protocol in Discovery Studio 4.5. I 
generated WRS dimer structure including N7-60 residues that chain A was 
superimposed on chain B. The two WRS monomers were built a symmetric 
structure. First step, the top 2,000 out of 54,000 docked poses of WRS dimer 
bound to 1:1 TLR4-MD2 were clustered and evaluated by ZDOCK. Thirteen 
docking models with high ZDOCK score were chosen by eye-selection for further 
refinement of energy optimization, a set of docked protein poses in RDOCK using 
CHARMM polar H force field. Three WRS dimer models bound to 1:1 TLR4-




dimer bound to 1:1 TLR4-MD2 poses from previous docking study for predicting 
dimerization of 2:2 TLR4-MD2 linking by WRS dimer. The top 85, 82 and 93 of 
54,000 respectively docked poses of 1:1 TLR4-MD2 bound to 1:1 TLR4-MD2-
WRS dimer were clustered and evaluated by ZDOCK. Three high-scoring and 
eye-selection docking models were selected by ZDOCK analysis. For further 
refinement of energy optimization each set of docked protein posed by RDOCK in 
the same manner. I selected final possible protein-protein docking model of 2:2 
TLR4-MD2 dimerization bound to WRS dimer using RDOCK energy and visual 
inspection 
Statistics 
Data are shown as means ± standard deviations (SD) or means ± standard error 




(ANOVA) following Tukey’s test using SPSS software (version 21, IBM-SPSS 
Inc., Chicago, IL). Two-tailed Mann-Whitney test was performed using GraphPad 
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감염에 대한 초기 면역 방어 시스템에서 
Tryptophanyl-tRNA Synthetase 의 역할 규명 
 
 
Tryptophanyl tRNA synthetase (WRS)는 aminoacyl tRNA 
synthetases(ARSs)의 일원으로 단백질 합성 과정에 필수적인 효소이다. 최
근 이 ARSs들이 본질적인 기능 이외에 다양한 생물학적 기능을 나타낸다는 
것이 잘 알려져 있다. 아미노기 부가부분(extra N-terminal domain)이 없
는 형태의 mini-WRS는 혈관신생억제 작용을 나타낸다는 것이 보고되었으
나 전체 길이의 WRS (full-length WRS; FL-WRS)의 역할에 대해 알려진 
바 없었다. 병원체(pathogen)에 의한 것이 아닌 비감염성 원인으로 유발된 
각종 전신 염증 반응 (systemic inflammatory response) 환자에서는 WRS
의 분비가 증가되지 않는 반면, 박테리아, 바이러스 또는 균류 (fungi)의 감




혈증 환자에서 WRS의 수준이 정상인에 비하여 크게 증가하였다.  
본 연구는 병원성 감염원 (세균, 바이러스, 곰팡이 등)이 침입하면 인간의 
단핵구로부터 세포질에 존재하던 FL-WRS가 수분 내에 분비되었다. 분비된 
FL-WRS는 TLR4-MD2 복합체와 결합하여 대식세포의 식작용을 증가시킴
과 동시에 케모카인 분비를 통하여 중성구 (Neutrophil) 유입을 유도함으로
서 초기에 감염원을 박멸한다는 것을 밝혔다. 생쥐에 살모넬라균을 감염시키
고 FL-WRS를 주입하면 살모넬라균 제거가 활발히 이루어져 생쥐의 생존 기
간이 늘어났으며 FL-WRS에 대한 중화 항체를 주입하여 FL-WRS의 작용
을 무력화시킨 경우 생쥐의 생존 기간이 줄어드는 것을 확인하였다. 이와 같
은 결과는 FL-WRS가 감염 초기에 감염원의 종류에 상관없이 병원균의 침입
을 막기 위한 초기 방어 시스템으로 작동한다는 것을 의미한다.  
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